© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 19, 1506-1507,
October 2, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
Re: Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
Affiliations of authors: F. Bertucci, D. Birnbaum (Department of Molecular Oncology), F. Eisinger, H. Sobol (Department of Oncogenetics and Cancer Prevention), Institut Paoli-Calmettes, Institut National de la Santé et de la Recherche Médicale Unité 119 and E9939, and Université de la Méditerranée, Marseille, France; R. Tagett, Ipsogen SA, Marseille.
Correspondence to: Daniel Birnbaum, M.D., Ph.D., Laboratoire d'Oncologie Moléculaire, Unité 119 Institut National de la Santé et de la Recherche Médicale, IFR57, 27 Bd. Leï Roure, 13009 Marseille, France (e-mail: birnbaum@marseille.inserm.fr).
| The first 10% of the full text of this article appears below. |
Hereditary breast and ovarian cancers are associated mainly with the inactivation of BRCA1 or BRCA2 tumor suppressor genes, but sporadic forms have also been associated with alterations in these genes (1). DNA microarrays (2) have the potential to reveal the complex mechanisms of oncogenesis. Jazaeri et al. (3) show that gene